Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis
Authors:
Ray S. Lin,
Ji Lin,
Satrajit Roychoudhury,
Keaven M. Anderson,
Tianle Hu,
Bo Huang,
Larry F Leon,
Jason JZ Liao,
Rong Liu,
Xiaodong Luo,
Pralay Mukhopadhyay,
Rui Qin,
Kay Tatsuoka,
Xuejing Wang,
Yang Wang,
Jian Zhu,
Tai-Tsang Chen,
Renee Iacona,
Cross-Pharma Non-proportional Hazards Working Group
Abstract:
The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan…
▽ More
The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and Restricted Mean Survival Time, RMST), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, type I error, and effect estimates of each method were compared. In general, all tests control type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the PH or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes overtime under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be pre-specified as sensitivity analyses to evaluate the totality of the data.
△ Less
Submitted 20 September, 2019;
originally announced September 2019.
